Piet Ost

28PUBLICATIONS
295CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressiveness.

|May 18, 2026
Germline polygenic score for prostate cancer aggressiveness.

|Dec 24, 2025
Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

Jennifer Le Guevelou, Thomas Zilli, Federica Ferrario

|Nov 27, 2025
Authors' reply to: comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'.

Lies Van den Eynde, Piet Ost, Nicolaas Lumen

|Sep 20, 2025
Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer.

Lies Van den Eynde, Piet Ost, Wesley Verla

Pageof 5

Frequent Collaborators

6 joint publications

Alexander Wyatt

6 joint publications

Nora Pashayan

6 joint publications

Jong Y Park

6 joint publications

Karina Dalsgaard Sørensen